Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy

Hayley C. Affronti, Aryn M. Rowsam, Anthony J. Pellerite, Spencer R. Rosario, Mark D. Long, Justine J. Jacobi, Anna Bianchi-Smiraglia, Christoph S. Boerlin, Bryan M. Gillard, Ellen Karasik, Barbara A. Foster, Michael Moser, John H. Wilton, Kristopher Attwood, Mikhail A. Nikiforov, Gissou Azabdaftari, Roberto Pili, James G. Phillips, Robert A. Casero, Dominic J. Smiraglia

Research output: Contribution to journalArticle

Abstract

Prostatic luminal epithelial cells secrete high levels of acetylated polyamines into the prostatic lumen, sensitizing them to perturbations of connected metabolic pathways. Enhanced flux is driven by spermidine/spermine N1-acetyltransferase (SSAT) activity, which acetylates polyamines leading to their secretion and drives biosynthetic demand. The methionine salvage pathway recycles one-carbon units lost to polyamine biosynthesis to the methionine cycle to overcome stress. Prostate cancer (CaP) relies on methylthioadenosine phosphorylase (MTAP), the rate-limiting enzyme, to relieve strain. Here, we show that inhibition of MTAP alongside SSAT upregulation is synergistic in androgen sensitive and castration recurrent CaP models in vitro and in vivo. The combination treatment increases apoptosis in radical prostatectomy ex vivo explant samples. This unique high metabolic flux through polyamine biosynthesis and connected one carbon metabolism in CaP creates a metabolic dependency. Enhancing this flux while simultaneously targeting this dependency in prostate cancer results in an effective therapeutic approach potentially translatable to the clinic.

Original languageEnglish (US)
Article number52
JournalNature communications
Volume11
Issue number1
DOIs
StatePublished - Dec 1 2020

Fingerprint

catabolism
Salvaging
methionine
Polyamines
Methionine
therapy
Prostatic Neoplasms
biosynthesis
Up-Regulation
cancer
Pharmacology
Acetyltransferases
Spermidine
Spermine
Biosynthesis
Fluxes
sensitizing
secretions
lumens
Carbon

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

Affronti, H. C., Rowsam, A. M., Pellerite, A. J., Rosario, S. R., Long, M. D., Jacobi, J. J., ... Smiraglia, D. J. (2020). Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy. Nature communications, 11(1), [52]. https://doi.org/10.1038/s41467-019-13950-4

Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy. / Affronti, Hayley C.; Rowsam, Aryn M.; Pellerite, Anthony J.; Rosario, Spencer R.; Long, Mark D.; Jacobi, Justine J.; Bianchi-Smiraglia, Anna; Boerlin, Christoph S.; Gillard, Bryan M.; Karasik, Ellen; Foster, Barbara A.; Moser, Michael; Wilton, John H.; Attwood, Kristopher; Nikiforov, Mikhail A.; Azabdaftari, Gissou; Pili, Roberto; Phillips, James G.; Casero, Robert A.; Smiraglia, Dominic J.

In: Nature communications, Vol. 11, No. 1, 52, 01.12.2020.

Research output: Contribution to journalArticle

Affronti, HC, Rowsam, AM, Pellerite, AJ, Rosario, SR, Long, MD, Jacobi, JJ, Bianchi-Smiraglia, A, Boerlin, CS, Gillard, BM, Karasik, E, Foster, BA, Moser, M, Wilton, JH, Attwood, K, Nikiforov, MA, Azabdaftari, G, Pili, R, Phillips, JG, Casero, RA & Smiraglia, DJ 2020, 'Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy', Nature communications, vol. 11, no. 1, 52. https://doi.org/10.1038/s41467-019-13950-4
Affronti, Hayley C. ; Rowsam, Aryn M. ; Pellerite, Anthony J. ; Rosario, Spencer R. ; Long, Mark D. ; Jacobi, Justine J. ; Bianchi-Smiraglia, Anna ; Boerlin, Christoph S. ; Gillard, Bryan M. ; Karasik, Ellen ; Foster, Barbara A. ; Moser, Michael ; Wilton, John H. ; Attwood, Kristopher ; Nikiforov, Mikhail A. ; Azabdaftari, Gissou ; Pili, Roberto ; Phillips, James G. ; Casero, Robert A. ; Smiraglia, Dominic J. / Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy. In: Nature communications. 2020 ; Vol. 11, No. 1.
@article{ba3d2e5a114849378e9fcca27113b624,
title = "Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy",
abstract = "Prostatic luminal epithelial cells secrete high levels of acetylated polyamines into the prostatic lumen, sensitizing them to perturbations of connected metabolic pathways. Enhanced flux is driven by spermidine/spermine N1-acetyltransferase (SSAT) activity, which acetylates polyamines leading to their secretion and drives biosynthetic demand. The methionine salvage pathway recycles one-carbon units lost to polyamine biosynthesis to the methionine cycle to overcome stress. Prostate cancer (CaP) relies on methylthioadenosine phosphorylase (MTAP), the rate-limiting enzyme, to relieve strain. Here, we show that inhibition of MTAP alongside SSAT upregulation is synergistic in androgen sensitive and castration recurrent CaP models in vitro and in vivo. The combination treatment increases apoptosis in radical prostatectomy ex vivo explant samples. This unique high metabolic flux through polyamine biosynthesis and connected one carbon metabolism in CaP creates a metabolic dependency. Enhancing this flux while simultaneously targeting this dependency in prostate cancer results in an effective therapeutic approach potentially translatable to the clinic.",
author = "Affronti, {Hayley C.} and Rowsam, {Aryn M.} and Pellerite, {Anthony J.} and Rosario, {Spencer R.} and Long, {Mark D.} and Jacobi, {Justine J.} and Anna Bianchi-Smiraglia and Boerlin, {Christoph S.} and Gillard, {Bryan M.} and Ellen Karasik and Foster, {Barbara A.} and Michael Moser and Wilton, {John H.} and Kristopher Attwood and Nikiforov, {Mikhail A.} and Gissou Azabdaftari and Roberto Pili and Phillips, {James G.} and Casero, {Robert A.} and Smiraglia, {Dominic J.}",
year = "2020",
month = "12",
day = "1",
doi = "10.1038/s41467-019-13950-4",
language = "English (US)",
volume = "11",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy

AU - Affronti, Hayley C.

AU - Rowsam, Aryn M.

AU - Pellerite, Anthony J.

AU - Rosario, Spencer R.

AU - Long, Mark D.

AU - Jacobi, Justine J.

AU - Bianchi-Smiraglia, Anna

AU - Boerlin, Christoph S.

AU - Gillard, Bryan M.

AU - Karasik, Ellen

AU - Foster, Barbara A.

AU - Moser, Michael

AU - Wilton, John H.

AU - Attwood, Kristopher

AU - Nikiforov, Mikhail A.

AU - Azabdaftari, Gissou

AU - Pili, Roberto

AU - Phillips, James G.

AU - Casero, Robert A.

AU - Smiraglia, Dominic J.

PY - 2020/12/1

Y1 - 2020/12/1

N2 - Prostatic luminal epithelial cells secrete high levels of acetylated polyamines into the prostatic lumen, sensitizing them to perturbations of connected metabolic pathways. Enhanced flux is driven by spermidine/spermine N1-acetyltransferase (SSAT) activity, which acetylates polyamines leading to their secretion and drives biosynthetic demand. The methionine salvage pathway recycles one-carbon units lost to polyamine biosynthesis to the methionine cycle to overcome stress. Prostate cancer (CaP) relies on methylthioadenosine phosphorylase (MTAP), the rate-limiting enzyme, to relieve strain. Here, we show that inhibition of MTAP alongside SSAT upregulation is synergistic in androgen sensitive and castration recurrent CaP models in vitro and in vivo. The combination treatment increases apoptosis in radical prostatectomy ex vivo explant samples. This unique high metabolic flux through polyamine biosynthesis and connected one carbon metabolism in CaP creates a metabolic dependency. Enhancing this flux while simultaneously targeting this dependency in prostate cancer results in an effective therapeutic approach potentially translatable to the clinic.

AB - Prostatic luminal epithelial cells secrete high levels of acetylated polyamines into the prostatic lumen, sensitizing them to perturbations of connected metabolic pathways. Enhanced flux is driven by spermidine/spermine N1-acetyltransferase (SSAT) activity, which acetylates polyamines leading to their secretion and drives biosynthetic demand. The methionine salvage pathway recycles one-carbon units lost to polyamine biosynthesis to the methionine cycle to overcome stress. Prostate cancer (CaP) relies on methylthioadenosine phosphorylase (MTAP), the rate-limiting enzyme, to relieve strain. Here, we show that inhibition of MTAP alongside SSAT upregulation is synergistic in androgen sensitive and castration recurrent CaP models in vitro and in vivo. The combination treatment increases apoptosis in radical prostatectomy ex vivo explant samples. This unique high metabolic flux through polyamine biosynthesis and connected one carbon metabolism in CaP creates a metabolic dependency. Enhancing this flux while simultaneously targeting this dependency in prostate cancer results in an effective therapeutic approach potentially translatable to the clinic.

UR - http://www.scopus.com/inward/record.url?scp=85077576977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077576977&partnerID=8YFLogxK

U2 - 10.1038/s41467-019-13950-4

DO - 10.1038/s41467-019-13950-4

M3 - Article

C2 - 31911608

AN - SCOPUS:85077576977

VL - 11

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

IS - 1

M1 - 52

ER -